The role of surface chemistry in determining invivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots

Biomaterials

Volumn 34, Issue 34, 2013, Pages 8741-8755

  Tang, Yuan ^a   Han, Songling ^a   Liu, Hongmei ^a   Chen, Xin ^a   Huang, Li ^a   Li, Xiaohui ^a   Zhang, Jianxiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Drug delivery; Imaging; Nanomedicine; Quantum dot; Surface chemistry; Toxicity

Indexed keywords

BIODISTRIBUTIONS; CORE-SHELL QUANTUM DOTS; INVIVO EVALUATIONS; LONG TERM EXPOSURE; POLYDIALLYLDIMETHYL AMMONIUM CHLORIDE; POSITIVELY CHARGED; PULMONARY EMBOLISM; QUANTUM DOT;

BIOLOGICAL ORGANS; CHLORINE COMPOUNDS; COATINGS; DRUG DELIVERY; IMAGING TECHNIQUES; MEDICAL NANOTECHNOLOGY; SEMICONDUCTOR QUANTUM DOTS; SURFACE CHEMISTRY;

TOXICITY;

CADMIUM; DIDECYLDIMETHYLAMMONIUM CHLORIDE; POLYDIALLYLDIMETHYLAMMONIUM CHLORIDE; QUANTUM DOT; SELENIUM; SULFUR; UNCLASSIFIED DRUG; ZINC;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMASS DISTRIBUTION; CHEMISTRY; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; LONG TERM EXPOSURE; LUNG; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SURFACE CHARGE; SURFACE PROPERTY;

DRUG DELIVERY; IMAGING; NANOMEDICINE; QUANTUM DOT; SURFACE CHEMISTRY; TOXICITY;

ANIMALS; CADMIUM COMPOUNDS; DRUG DELIVERY SYSTEMS; LETHAL DOSE 50; LIVER; LUNG; MALE; MICE; MICE, INBRED BALB C; NANOMEDICINE; POLYETHYLENES; QUANTUM DOTS; QUATERNARY AMMONIUM COMPOUNDS; SELENIUM COMPOUNDS; SULFIDES; SURFACE PROPERTIES; TISSUE DISTRIBUTION; ZINC COMPOUNDS;

EID: 84882846247     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.087     Document Type: Article

References (65)

1. Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanomedicine. NEngl J Med 2010, 363:2434-2443.
2. Torney F., Trewyn B.G., Lin V.S.Y., Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2007, 2:295-300.
3. Mortensen L.J., Oberdorster G., Pentland A.P., DeLouise L.A. Invivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 2008, 8:2779-2787.
4. Bhabra G., Sood A., Fisher B., Cartwright L., Saunders M., Evans W.H., et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009, 4:876-883.
5. Yamashita K., Yoshioka Y., Higashisaka K., Mimura K., Morishita Y., Nozaki M., et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 2011, 6:321-328.
6. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
7. Kirchner C., Liedl T., Kudera S., Pellegrino T., Javier A.M., Gaub H.E., et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 2005, 5:331-338.
8. Jiang W., Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008, 3:145-150.
9. Verma A., Uzun O., Hu Y.H., Hu Y., Han H.S., Watson N., et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 2008, 7:588-595.
10. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M.V., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8:543-557.
11. Cho E.C., Au L., Zhang Q., Xia Y.N. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 2010, 6:517-522.
12. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
13. Mahmoudi M., Azadmanesh K., Shokrgozar M.A., Journeay W.S., Laurent S. Effect of nanoparticles on the cell life cycle. Chem Rev 2011, 111:3407-3432.
14. Soenen S.J., Rivera-Gil P., Montenegro J.M., Parak W.J., De Smedt S.C., Braeckmans K. Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 2011, 6:446-465.
15. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
16. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007, 2:469-478.
17. Krug H.F., Wick P. Nanotoxicology: an interdisciplinary challenge. Angew Chem Int Ed 2011, 50:1260-1278.
18. Alivisatos A.P., Gu W.W., Larabell C. Quantum dots as cellular probes. Annu Rev Biomed Eng 2005, 7:55-76.
19. Smith A.M., Duan H.W., Mohs A.M., Nie S.M. Bioconjugated quantum dots for invivo molecular and cellular imaging. Adv Drug Deliv Rev 2008, 60:1226-1240.
20. Zrazhevskiy P., Sena M., Gao X.H. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev 2010, 39:4326-4354.
21. Zhang L.W., Monteiro-Riviere N.A. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 2009, 110:138-155.
22. Gosso S., Gavello D., Giachello C.N.G., Franchino C., Carbone E., Carabelli V. The effect of CdSeZnS quantum dots on calcium currents and catecholamine secretion in mouse chromaffin cells. Biomaterials 2011, 32:9040-9050.
23. Chou L.Y.T., Ming K., Chan W.C.W. Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev 2011, 40:233-245.
24. Chen N., He Y., Su Y.Y., Li X.M., Huang Q., Wang H.F., et al. The cytotoxicity of cadmium-based quantum dots. Biomaterials 2012, 33:1238-1244.
25. Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y.F., Ohta T., et al. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 2004, 4:2163-2169.
26. Clift M.J.D., Varet J., Hankin S.M., Brownlee B., Davidson A.M., Brandenberger C., et al. Quantum dot cytotoxicity invitro: an investigation into the cytotoxic effects of a series of different surface chemistries and their core/shell materials. Nanotoxicology 2011, 5:664-674.
27. Walkey C.D., Olsen J.B., Guo H.B., Emili A., Chan W.C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. JAm Chem Soc 2011, 134:2139-2147.
28. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
29. Hardman R. Atoxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114:165-172.
30. Lee J., Lilly G.D., Doty R.C., Podsiadlo P., Kotov N.A. Invitro toxicity testing of nanoparticles in 3D cell culture. Small 2009, 5:1213-1221.
31. Lin P.P., Chen J.W., Chang L.W., Wu J.P., Redding L., Chang H., et al. Computational and ultrastructural toxicology of a nanoparticle, quantum dot 705, in mice. Environ Sci Technol 2008, 42:6264-6270.
32. Hauck T.S., Anderson R.E., Fischer H.C., Newbigging S., Chan W.C.W. Invivo quantum-dot toxicity assessment. Small 2010, 6:138-144.
33. Lin C.H., Yang M.H., Chang L.W., Yang C.S., Chang H., Chang W.H., et al. Cd/Se/Te-based quantum dot 705 modulated redox homeostasis with hepatotoxicity in mice. Nanotoxicology 2011, 5:650-663.
34. Liu W., Zhang S.P., Wang L.X., Qu C., Zhang C.W., Hong L., et al. CdSe quantum dot (QD)-induced morphological and functional impairments to liver in mice. PLoS ONE 2011, 6:e24406.
35. Ho C.C., Chang H., Tsai H.T., Tsai M.H., Yang C.S., Ling Y.C., et al. Quantum Dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung. Nanotoxicology 2013, 7:105-115.
36. Ye L., Yong K.T., Liu L.W., Roy I., Hu R., Zhu J., et al. Apilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat Nanotechnol 2012, 7:453-458.
37. Ambrosone A., Mattera L., Marchesano V., Quarta A., Susha A.S., Tino A., et al. Mechanisms underlying toxicity induced by CdTe quantum dots determined in an invertebrate model organism. Biomaterials 2012, 33:1991-2000.
38. Roberts J.R., Antonini J.M., Porter D.W., Chapman R.S., Scabilloni J.F., Young S.H., et al. Lung toxicity and biodistribution of Cd/Se-ZnS quantum dots with different surface functional groups after pulmonary exposure in rats. Part Fibre Toxicol 2013, 10:1-17.
39. Fischer H.C., Liu L.C., Pang K.S., Chan W.C.W. Pharmacokinetics of nanoscale quantum dots: invivo distribution, sequestration, and clearance in the rat. Adv Funct Mater 2006, 16:1299-1305.
40. Yang R.S.H., Chang L.W., Wu J.P., Tsai M.H., Wang H.J., Kuo Y.C., et al. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 2007, 115:1339-1343.
41. Choi H.S., Liu W.H., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
42. Fitzpatrick J.A.J., Andreko S.K., Ernst L.A., Waggoner A.S., Ballou B., Bruchez M.P. Long-term persistence and spectral blue shifting of quantum dots invivo. Nano Lett 2009, 9:2736-2741.
43. Schipper M.L., Lyer G., Koh A.L., Cheng Z., Ebenstein Y., Aharoni A., et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5:126-134.
44. Gil P.R., Oberdorster G., Elder A., Puntes V., Parak W.J. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010, 4:5527-5531.
45. Li J.J., Wang Y.A., Guo W.Z., Keay J.C., Mishima T.D., Johnson M.B., et al. Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. JAm Chem Soc 2003, 125:12567-12575.
46. Sun Q.J., Wang Y.A., Li L.S., Wang D.Y., Zhu T., Xu J., et al. Bright, multicoloured light-emitting diodes based on quantum dots. Nat Photonics 2007, 1:717-722.
47. Gao X.H., Cui Y.Y., Levenson R.M., Chung L.W.K., Nie S.M. Invivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
48. Geys J., Nemmar A., Verbeken E., Smolders E., Ratoi M., Hoylaerts M.F., et al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 2008, 116:1607-1613.
49. Yu W.W., Qu L.H., Guo W.Z., Peng X.G. Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals. Chem Mater 2003, 15:2854-2860.
50. Choi H.S., Liu W.H., Liu F.B., Nasr K., Misra P., Bawendi M.G., et al. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 2010, 5:42-47.
51. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22:93-97.
52. So M.K., Xu C.J., Loening A.M., Gambhir S.S., Rao J.H. Self-illuminating quantum dot conjugates for invivo imaging. Nat Biotechnol 2006, 24:339-343.
53. Yong K.T., Roy I., Ding H., Bergey E.J., Prasad P.N. Biocompatible nar-infrared quantum dots as ultrasensitive probes for long-term invivo imaging applications. Small 2009, 5:1997-2004.
54. Chang E., Thekkek N., Yu W.W., Colvin V.L., Drezek R. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2006, 2:1412-1417.
55. Hauck T.S., Ghazani A.A., Chan W.C.W. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 2008, 4:153-159.
56. Fischer D., Dautzenberg H., Kunath K., Kissel T. Poly(diallyldimethylammonium chlorides) and their N-methyl-N-vinylacetamide copolymer-based DNA-polyplexes: role of molecular weight and charge density in complex formation, stability, and invitro activity. Int J Pharm 2004, 280:253-269.
57. Krajcik R., Jung A., Hirsch A., Neuhuber W., Zolk O. Functionalization of carbon nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for efficient knock-down of genes. Biochem Biophys Res Commun 2008, 369:595-602.
58. Melo L.D., Mamizuka E.M., Carmona-Ribeiro A.M. Antimicrobial particles from cationic lipid and polyelectrolytes. Langmuir 2010, 26:12300-12306.
59. Bertrand N., Leroux J.C. The journey of a drug-carrier in the body: an anatomo-physiological perspective. JControl Release 2012, 161:152-163.
60. Kutscher H.L., Chao P., Deshmukh M., Singh Y., Hu P., Joseph L.B., et al. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. JControl Release 2010, 143:31-37.
61. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
62. Harrison K.L. Fetal erythrocyte lifespan. Aust Paediatr J 1979, 15:96-97.
63. Chollet P., Favrot M.C., Hurbin A., Coll J.L. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. JGene Med 2002, 4:84-91.
64. Akagi D., Oba M., Koyama H., Nishiyama N., Fukushima S., Miyata T., et al. Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. Gene Ther 2007, 14:1029-1038.
65. Hunter A.C., Moghimi S.M. Cationic carriers of genetic material and cell death: a mitochondrial tale. Biochim Biophys Acta 2010, 1797:1203-1209.